NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US Application 62/633,517Filed on 2018-02-21
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE Read more about RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE US Application 62/512,111Filed on 2017-05-29
Complete Sequence Of The Genome Of Avian Parayxovirus Type 2 Read more about Complete Sequence Of The Genome Of Avian Parayxovirus Type 2 US Application 61/218,851Filed on 2009-06-19
RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE Read more about RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US Application 62/572,973Filed on 2017-10-16
ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES Read more about ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES US Application 62/567,079Filed on 2017-10-02
Delaying MVA Induced Apoptosis For Enhancing Immunogenicity (B13R) Read more about Delaying MVA Induced Apoptosis For Enhancing Immunogenicity (B13R) US Application 62/402,669Filed on 2016-09-30
NOVEL RECOMBINANT PREFUSION RSV F PROTEINS AND USES THEREOF Read more about NOVEL RECOMBINANT PREFUSION RSV F PROTEINS AND USES THEREOF US Application 62/435,275Filed on 2016-12-16
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US Application 62/612,982Filed on 2018-01-02
Glycan-Masked Engineered Outer Domains of HIV-1 GP120 and Their Use Read more about Glycan-Masked Engineered Outer Domains of HIV-1 GP120 and Their Use US Application 62/476,397Filed on 2017-03-24